| Year |
Citation |
Score |
| 2021 |
Gwynne WD, Shakeel MS, Girgis-Gabardo A, Hassell JA. The Role of Serotonin in Breast Cancer Stem Cells. Molecules (Basel, Switzerland). 26. PMID 34073226 DOI: 10.3390/molecules26113171 |
0.4 |
|
| 2020 |
Gwynne WD, Shakeel MS, Girgis-Gabardo A, Kim KH, Ford E, Dvorkin-Gheva A, Aarts C, Isaac M, Al-Awar R, Hassell JA. Antagonists of the serotonin receptor 5A target human breast tumor initiating cells. Bmc Cancer. 20: 724. PMID 32758183 DOI: 10.1186/s12885-020-07193-6 |
0.37 |
|
| 2019 |
Gwynne WD, Shakeel MS, Wu J, Hallett RM, Girgis-Gabardo A, Dvorkin-Gheva A, Hassell JA. Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells. Cellular & Molecular Biology Letters. 24: 59. PMID 31754354 DOI: 10.1186/s11658-019-0183-8 |
0.375 |
|
| 2019 |
Atiya HI, Dvorkin-Gheva A, Hassell J, Patel S, Parker RL, Hartstone-Rose A, Hodge J, Fan D, Ramsdell AF. Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis. Anticancer Research. 39: 2277-2287. PMID 31092419 DOI: 10.21873/Anticanres.13344 |
0.463 |
|
| 2017 |
Shenouda MM, Gillgrass A, Nham T, Hogg R, Lee AJ, Chew MV, Shafaei M, Aarts C, Lee DA, Hassell J, Bane A, Dhesy-Thind S, Ashkar AA. Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. Breast Cancer Research : Bcr. 19: 76. PMID 28668076 DOI: 10.1186/S13058-017-0867-9 |
0.401 |
|
| 2017 |
Gwynne WD, Hallett RM, Girgis-Gabardo A, Bojovic B, Dvorkin-Gheva A, Aarts C, Dias K, Bane A, Hassell JA. Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts. Oncotarget. PMID 28404880 DOI: 10.18632/oncotarget.16646 |
0.383 |
|
| 2017 |
Bassey-Archibong BI, Rayner LG, Hercules SM, Aarts CW, Dvorkin-Gheva A, Bramson JL, Hassell JA, Daniel JM. Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells. Cell Death & Disease. 8: e2689. PMID 28333150 DOI: 10.1038/cddis.2017.92 |
0.429 |
|
| 2017 |
Dias K, Dvorkin-Gheva A, Hallett RM, Wu Y, Hassell J, Pond GR, Levine M, Whelan T, Bane AL. Claudin-Low Breast Cancer; Clinical & Pathological Characteristics. Plos One. 12: e0168669. PMID 28045912 DOI: 10.1371/Journal.Pone.0168669 |
0.482 |
|
| 2017 |
Gillgrass A, Pond G, Levine M, Whelan T, Hassell J, Bane A. Abstract P4-12-09: The immune response in triple negative breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P4-12-09 |
0.417 |
|
| 2016 |
Hallett RM, Girgis-Gabardo A, Gwynne WD, Giacomelli AO, Bisson JN, Jensen JE, Dvorkin-Gheva A, Hassell JA. Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer. Oncotarget. PMID 27447971 DOI: 10.18632/oncotarget.10614 |
0.39 |
|
| 2016 |
Bassey-Archibong BI, Kwiecien JM, Milosavljevic SB, Hallett RM, Rayner LG, Erb MJ, Crawford-Brown CJ, Stephenson KB, Bédard PA, Hassell JA, Daniel JM. Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cells. Oncogenesis. 5: e208. PMID 26999717 DOI: 10.1038/oncsis.2016.17 |
0.385 |
|
| 2016 |
Gwynne W, Hallett R, Girgis-Gabardo A, Dvorkin-Gheva A, Hassell J. Serotonergic antagonists target breast tumor-initiating cells in mouse models of human breast cancer European Journal of Cancer. 69: S83. DOI: 10.1016/S0959-8049(16)32842-8 |
0.372 |
|
| 2015 |
Qazi MA, Vora P, Venugopal C, McFarlane N, Subapanditha MK, Murty NK, Hassell JA, Hallett RM, Singh SK. A novel stem cell culture model of recurrent glioblastoma. Journal of Neuro-Oncology. PMID 26498281 DOI: 10.1007/S11060-015-1951-6 |
0.327 |
|
| 2015 |
Robichaux JP, Hallett RM, Fuseler JW, Hassell JA, Ramsdell AF. Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice. Oncogene. 34: 2003-10. PMID 24909172 DOI: 10.1038/Onc.2014.149 |
0.387 |
|
| 2015 |
Jerzak KJ, Cockburn J, Pond GR, Hallett R, Hassell J, Pritchard KI, Dhesy-Thind SK, Bane A. Expression of thyroid hormone receptor alpha (THRα) isoforms in triple negative breast cancer (TNBC). Journal of Clinical Oncology. 33: e12082-e12082. DOI: 10.1200/Jco.2015.33.15_Suppl.E12082 |
0.4 |
|
| 2015 |
Li B, Hallet R, Wu Y, Pong G, Hassell J, Hotte S, Levine M, Lukka H, Bane A. Abstract 4346: Prognostic gene signature for intermediate risk prostate cancer Cancer Research. 75: 4346-4346. DOI: 10.1158/1538-7445.Am2015-4346 |
0.348 |
|
| 2015 |
Venugopal C, Hallett R, Vora P, Manoranjan B, Mahendram S, Qazi M, McFarlane N, Subapanditha M, Nolte S, Singh M, Bakhshinyan D, Garg N, Boleslaw L, John P, Reddy K, ... ... Hassell J, et al. STEM-23PYRVINIUM TARGETS CD133 IN HUMAN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS Neuro-Oncology. 17: v213.1-v213. DOI: 10.1093/Neuonc/Nov234.23 |
0.352 |
|
| 2015 |
Singh M, Venugopal C, McFarlane N, Bakhshinyan D, Mahendram S, Brown K, Tong A, Durrer K, Hallett R, Hassell J, Moffat J, Singh S. BMET-31DEVELOPMENT AND APPLICATION OF A NOVEL MODEL OF HUMAN LUNG-TO-BRAIN METASTASIS TO IDENTIFY UNIQUE METASTATIC GENE SIGNATURES Neuro-Oncology. 17: v51.5-v52. DOI: 10.1093/Neuonc/Nov208.31 |
0.406 |
|
| 2015 |
Manoranjan B, Venugopal C, Mahendram S, Moreira S, Hallett R, Vijayakumar T, Bakhshinyan D, McFarlane N, Hassell J, Doble B, Singh S. MB-15 * ACTIVATED Wnt SIGNALING TARGETS Sox2+ TREATMENT-REFRACTORY Shh-DEPENDENT MEDULLOBLASTOMA STEM CELLS Neuro-Oncology. 17: iii23-iii23. DOI: 10.1093/Neuonc/Nov061.91 |
0.4 |
|
| 2014 |
Hallett RM, Hassell JA. Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer. Bmc Cancer. 14: 871. PMID 25420785 DOI: 10.1186/1471-2407-14-871 |
0.38 |
|
| 2013 |
Manoranjan B, Wang X, Hallett RM, Venugopal C, Mack SC, McFarlane N, Nolte SM, Scheinemann K, Gunnarsson T, Hassell JA, Taylor MD, Lee C, Triscott J, Foster CM, Dunham C, et al. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells. Stem Cells (Dayton, Ohio). 31: 1266-77. PMID 23592496 DOI: 10.1002/stem.1401 |
0.407 |
|
| 2013 |
Kurpios NA, Girgis-Gabardo A, Hallett RM, Rogers S, Gludish DW, Kockeritz L, Woodgett J, Cardiff R, Hassell JA. Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hosts. Plos One. 8: e58151. PMID 23555570 DOI: 10.1371/Journal.Pone.0058151 |
0.352 |
|
| 2012 |
Hallett RM, Pond G, Hassell JA. A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy. Bmc Medical Genomics. 5: 16. PMID 22578285 DOI: 10.1186/1755-8794-5-16 |
0.329 |
|
| 2012 |
Hallett RM, Kondratyev MK, Giacomelli AO, Nixon AM, Girgis-Gabardo A, Ilieva D, Hassell JA. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer. Plos One. 7: e33976. PMID 22470504 DOI: 10.1371/journal.pone.0033976 |
0.345 |
|
| 2012 |
Kondratyev M, Kreso A, Hallett RM, Girgis-Gabardo A, Barcelon ME, Ilieva D, Ware C, Majumder PK, Hassell JA. Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer. Oncogene. 31: 93-103. PMID 21666715 DOI: 10.1038/onc.2011.212 |
0.366 |
|
| 2011 |
Dvorkin-Gheva A, Hassell JA. Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples. Plos One. 6: e26023. PMID 22022496 DOI: 10.1371/journal.pone.0026023 |
0.413 |
|
| 2011 |
Hallett RM, Hassell JA. E2F1 and KIAA0191 expression predicts breast cancer patient survival. Bmc Research Notes. 4: 95. PMID 21453498 DOI: 10.1186/1756-0500-4-95 |
0.344 |
|
| 2010 |
Hebbard LW, Maurer J, Miller A, Lesperance J, Hassell J, Oshima RG, Terskikh AV. Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo. Cancer Research. 70: 8863-73. PMID 20861186 DOI: 10.1158/0008-5472.Can-10-1295 |
0.54 |
|
| 2010 |
Zhang Z, Sui P, Dong A, Hassell J, Cserjesi P, Chen YT, Behringer RR, Sun X. Preaxial polydactyly: interactions among ETV, TWIST1 and HAND2 control anterior-posterior patterning of the limb. Development (Cambridge, England). 137: 3417-26. PMID 20826535 DOI: 10.1242/Dev.051789 |
0.402 |
|
| 2010 |
Hallett RM, Dvorkin A, Gabardo CM, Hassell JA. An algorithm to discover gene signatures with predictive potential. Journal of Experimental & Clinical Cancer Research : Cr. 29: 120. PMID 20813028 DOI: 10.1186/1756-9966-29-120 |
0.351 |
|
| 2010 |
Baker R, Kent CV, Silbermann RA, Hassell JA, Young LJ, Howe LR. Pea3 transcription factors and wnt1-induced mouse mammary neoplasia. Plos One. 5: e8854. PMID 20107508 DOI: 10.1371/journal.pone.0008854 |
0.476 |
|
| 2009 |
Lu BC, Cebrian C, Chi X, Kuure S, Kuo R, Bates CM, Arber S, Hassell J, MacNeil L, Hoshi M, Jain S, Asai N, Takahashi M, Schmidt-Ott KM, Barasch J, et al. Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. Nature Genetics. 41: 1295-302. PMID 19898483 DOI: 10.1038/Ng.476 |
0.386 |
|
| 2009 |
Kurpios NA, MacNeil L, Shepherd TG, Gludish DW, Giacomelli AO, Hassell JA. The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development. Developmental Biology. 325: 106-21. PMID 18977342 DOI: 10.1016/J.Ydbio.2008.09.033 |
0.65 |
|
| 2005 |
Chen C, Ouyang W, Grigura V, Zhou Q, Carnes K, Lim H, Zhao GQ, Arber S, Kurpios N, Murphy TL, Cheng AM, Hassell JA, Chandrashekar V, Hofmann MC, Hess RA, et al. ERM is required for transcriptional control of the spermatogonial stem cell niche. Nature. 436: 1030-4. PMID 16107850 DOI: 10.1038/Nature03894 |
0.317 |
|
| 2005 |
Youn BS, Sen A, Kallos MS, Behie LA, Girgis-Gabardo A, Kurpios N, Barcelon M, Hassell JA. Large-scale expansion of mammary epithelial stem cell aggregates in suspension bioreactors. Biotechnology Progress. 21: 984-93. PMID 15932284 DOI: 10.1021/Bp050059F |
0.322 |
|
| 2005 |
Hesselbrock DR, Kurpios N, Hassell JA, Watson MA, Fleming TP. PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin. Breast Cancer Research and Treatment. 89: 289-96. PMID 15754128 DOI: 10.1007/s10549-004-2622-z |
0.352 |
|
| 2004 |
White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 6: 159-70. PMID 15324699 DOI: 10.1016/J.Ccr.2004.06.025 |
0.375 |
|
| 2004 |
Discenza MT, Vaz D, Hassell JA, Pelletier J. Activation of the WT1 tumor suppressor gene promoter by Pea3. Febs Letters. 560: 183-91. PMID 14988020 DOI: 10.1016/S0014-5793(04)00104-8 |
0.416 |
|
| 2003 |
Kurpios NA, Sabolic NA, Shepherd TG, Fidalgo GM, Hassell JA. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. Journal of Mammary Gland Biology and Neoplasia. 8: 177-90. PMID 14635793 DOI: 10.1023/A:1025948823955 |
0.671 |
|
| 2001 |
Shepherd TG, Kockeritz L, Szrajber MR, Muller WJ, Hassell JA. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Current Biology : Cb. 11: 1739-48. PMID 11719215 DOI: 10.1016/S0960-9822(01)00536-X |
0.653 |
|
| 2001 |
Shepherd T, Hassell JA. Role of Ets transcription factors in mammary gland development and oncogenesis. Journal of Mammary Gland Biology and Neoplasia. 6: 129-40. PMID 11467448 DOI: 10.1023/A:1009576801226 |
0.682 |
|
| 2001 |
Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, Brown AM. PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. The Journal of Biological Chemistry. 276: 20108-15. PMID 11274170 DOI: 10.1074/Jbc.M010692200 |
0.342 |
|
| 2001 |
Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA, Matrisian LM. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Molecular and Cellular Biology. 21: 1370-83. PMID 11158322 DOI: 10.1128/Mcb.21.4.1370-1383.2001 |
0.377 |
|
| 1998 |
O'Hagan RC, Hassell JA. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase. Oncogene. 16: 301-10. PMID 9467955 DOI: 10.1038/sj.onc.1201547 |
0.351 |
|
| 1997 |
Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong X, Chew K, Ljung BM, Edgerton S, Thor A, Hassell JA. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene. 15: 1513-25. PMID 9380403 DOI: 10.1038/sj.onc.1201331 |
0.447 |
|
| 1992 |
Xin JH, Cowie A, Lachance P, Hassell JA. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes & Development. 6: 481-96. PMID 1547944 DOI: 10.1101/gad.6.3.481 |
0.335 |
|
| 1989 |
Martínez-Salas E, Linney E, Hassell J, DePamphilis ML. The need for enhancers in gene expression first appears during mouse development with formation of the zygotic nucleus. Genes & Development. 3: 1493-506. PMID 2558965 DOI: 10.1101/Gad.3.10.1493 |
0.445 |
|
| 1977 |
Hassell J, Engelhardt DL. Factors regulating the multiplication of animal cells in culture. Experimental Cell Research. 107: 159-67. PMID 405232 DOI: 10.1016/0014-4827(77)90397-4 |
0.317 |
|
| Show low-probability matches. |